 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PSID to Exhibit at Major Conference |
|
 Hot Stock to Watch |
Company: PositiveID Corporation (OTCQB: PSID)
|
Last:
Price: 0.0012
Change (%): - 0.0002 (14.29)
Volume: 12,454,526 |
 |
PositiveID Corporation to Exhibit at the AMSUS Federal Health 2016 Conference
PositiveID to exhibit its Caregiver non-contact thermometer and Firefly Dx point-of-need pathogen detection system
DELRAY BEACH, Fla., Nov. 14, 2016 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it will exhibit its Caregiver® non-contact, infrared thermometer and its Firefly Dx point-of-need pathogen detection system at the AMSUS Federal Health 2016 Conference at the Gaylord National Resort and Convention Center in National Harbor, MD from November 29-December 2, 2016.
Caregiver is a clinical-grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds. Since Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone.
PositiveID is developing the Firefly Dx polymerase chain reaction (“PCR”) prototype system to be a handheld, fully automated, lab quality, real-time device able to detect bio-threats at the point of need. Currently, PCR tests are run on large lab equipment and take a minimum of four hours to deliver results. A design advantage of Firefly Dx is that it does not require additional equipment or separate steps for sample preparation and purification, unlike current lab-based equipment, thus reducing time to results as well as cost per test.
AMSUS - the Society of Federal Health Professionals - was established in 1891 and chartered by an Act of Congress in 1903. The medical services of the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, Department of Homeland Security and the medical departments other federal agencies form the constituency of the Association. AMSUS’ objectives are to advance the knowledge of federal and military medicine, to increase the efficiency of its membership by providing a forum for discussion of common ideas and issues, and provide continuing education opportunities for its members.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
